The Effect of Guided Imagery on Bonding and Breastfeeding After Cesarean

April 26, 2022 updated by: Menekşe Nazlı AKER

The Effect of Guided Imagery on Bonding and Breastfeeding After Cesarean; A Randomized Controlled Study

The aim of this study is to evaluate the effect of guided imagery after cesarean section on mother-infant bonding and breastfeeding.

The study will be carried out in two different groups. The practice will start with meeting the women 6-10 hours after cesarean section. After the women are evaluated in terms of eligibility criteria for the research, the women who are eligible will be informed about the research and written informed consent will be obtained from the women who accept. The random distribution of women to the study groups will be carried out using the Block Randomization method. The following applications will be made to the groups.

Intervention Group; The individuals in this group will be provided with guided imagery application. Guided imagery will be applied to the participants in the hospital environment 6-10 hours after the cesarean section. Afterwards, guided imagery application will be requested every day for two weeks.

Control Group; The participants in the control group will perform routine care of the clinic.

Study Overview

Status

Not yet recruiting

Conditions

Intervention / Treatment

Study Type

Interventional

Enrollment (Anticipated)

64

Phase

  • Not Applicable

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Contact

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

18 years and older (Adult, Older Adult)

Accepts Healthy Volunteers

Yes

Genders Eligible for Study

Female

Description

Inclusion Criteria:

  • Nullipar
  • Single birth
  • Baby being with mother
  • Gestational age 37-42 weeks
  • Birth weight between 2500-4000 g
  • APGAR score of 7 or higher in the 1st and 5th minutes
  • The mother does not have a health problem that prevents breastfeeding
  • Absence of conditions that prevent sucking, such as frenulum or palate problems

Exclusion Criteria:

  • Participant's non-compliance with the research plan
  • Interruption of breastfeeding for reasons such as health problems of the mother or baby
  • Participants receive professional support for breastfeeding during the study process
  • Hearing loss and deafness

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: Supportive Care
  • Allocation: Randomized
  • Interventional Model: Parallel Assignment
  • Masking: Double

Arms and Interventions

Participant Group / Arm
Intervention / Treatment
Experimental: Guided imagery Group
Guided imagery after cesarean
The individuals in this group will be provided with guided imagery application. Guided imagery will be applied to the participants in the hospital environment 6-10 hours after the cesarean section. Afterwards, guided imagery application will be requested every day for two weeks.
No Intervention: Standard care
The participants in the control group will perform routine care of the clinic.

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Change in how to feed baby
Time Frame: Baseline, 7th day, 14th day
Nutrient content that she feeds her baby (Breastmilk, formula etc)
Baseline, 7th day, 14th day
Change in The Mother-to-Infant Bonding Scale
Time Frame: Baseline, 7th day, 14th day
The scale consists of eight adjectives (loving, resentful, neutral or felt nothing, joyful, dislike, protective, disappointed and aggressive), each followed by a four-point Likert scale ranging from "Very much" (0) to "Not at all" (5). When the adjective reflects a negative emotional response, the scoring is reversed. Thus, possible scores on the scale range between 0 and 24, with high scores indicating a problematic mother-to-infant bond (Taylor et al. 2005).
Baseline, 7th day, 14th day
Change in Breastfeeding Self-Efficacy Scale
Time Frame: Baseline, 7th day, 14th day
The 14-item scale was developed by Dennis (2003). The scale is a 5-point Likert-type scale (1= 'I am not sure at all' and 5 = 'I am always sure'). The scale's minimum score is 14 and the maximum score is 70. An elevated score shows an increase in breastfeeding self-efficacy.
Baseline, 7th day, 14th day

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Change in Perception of Insufficient Milk Questionnaire
Time Frame: Baseline, 7th day, 14th day
This scale, developed by McCarter-Spaulding for determining the perception of insufficient breast milk, is a six-question form. The scale's minimum score is 0 and the maximum score is 50. A high total score indicates that milk sufficiency perception is also high.
Baseline, 7th day, 14th day

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Anticipated)

May 1, 2022

Primary Completion (Anticipated)

December 1, 2022

Study Completion (Anticipated)

December 1, 2022

Study Registration Dates

First Submitted

April 19, 2022

First Submitted That Met QC Criteria

April 19, 2022

First Posted (Actual)

April 25, 2022

Study Record Updates

Last Update Posted (Actual)

May 2, 2022

Last Update Submitted That Met QC Criteria

April 26, 2022

Last Verified

April 1, 2022

More Information

Terms related to this study

Other Study ID Numbers

  • 0555

Plan for Individual participant data (IPD)

Plan to Share Individual Participant Data (IPD)?

UNDECIDED

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Breastfeeding

Clinical Trials on Guided imagery

3
Subscribe